Dr. Sohn leads amfAR’s TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program and chairs the Executive Committee of the NIH-funded IeDEA (International Epidemiology Databases to Evaluate AIDS) global cohort consortium.
NEW YORK, March 15, 2018 — amfAR, The Foundation for AIDS Research, is pleased to announce the appointment of its Vice President and Director of TREAT Asia, Annette Sohn, M.D., as an editor-in-chief of the Journal of the International AIDS Society (JIAS), the open-access, peer-reviewed medical journal of the International AIDS Society (IAS).
Dr. Sohn leads amfAR’s TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program, a collaborative network of clinics, hospitals and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments to adults and children across the Asia-Pacific through research, education, community advocacy, and policy. Her own research focuses on long-term treatment outcomes of children and adolescents, and transitions from pediatric to adult HIV care.
“Dr. Sohn is a highly esteemed clinician and researcher whose work in pediatric HIV is incredibly vital to the field,” IAS President Linda-Gail Bekker said. “She also brings expertise in bridging research, with clinical training, community outreach and advocacy that will no doubt reflect upon and strengthen future JIAS scholarship. This is a greatly welcomed addition to the team.”
Under Dr. Sohn’s leadership since 2008, amfAR’s TREAT Asia program has brought together researchers, doctors, activists, and policymakers in the region’s response to HIV/AIDS, and has become a model for regional collaboration in combating the epidemic. TREAT Asia also plays a key advocacy role in the region, using data gathered through the network and its research to make the case for evidence-based HIV-related policy and programming.
“I am honored to be joining the editorial team at JIAS,” said Dr. Sohn. “The field of HIV research is constantly expanding with innovative studies that bring us closer to ending the global epidemic. I look forward to helping expand a knowledge base that has the potential to benefit millions of lives worldwide.”
Dr. Sohn is a member of the World Health Organization’s Strategic and Technical Advisory Committee on HIV and Viral Hepatitis, and Global Validation Advisory Committee on Elimination of Mother-to-Child Transmission of HIV and Syphilis. Dr. Sohn chairs the Executive Committee of the NIH-funded IeDEA (International Epidemiology Databases to Evaluate AIDS) global cohort consortium. She is on the Program Committee of the Conference on Retroviruses and Opportunistic Infections (CROI), and co-chairs the Asia Pacific AIDS and Co-infections Conference (APACC). She is also an assistant clinical professor in the Department of Pediatrics at the University of California, San Francisco.
Dr. Sohn graduated from Wellesley College and the School of Medicine at the University of California, Los Angeles, and completed her pediatrics residency and infectious diseases fellowship training at the University of California, San Francisco. She was an Epidemic Intelligence Service Officer at the U.S. Centers for Disease Control and Prevention.
Dr. Sohn will be joining a team of two highly regarded JIAS co-Editors-in-Chief, Professors Kenneth Mayer and Susan Kippax. Founded in 2004, JIAS is an open-access, PubMed- and Medline-indexed journal. Its primary purpose is to provide a platform for the generation and dissemination of HIV-related research, across a wide range of disciplines. Receiving over 600 submissions per year, JIAS aims to strengthen capacity and empower less experienced researchers from resource-limited countries.
# # #
About amfAR
amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has invested more than $517 million in its programs and has awarded more than 3,300 grants to research teams worldwide.